Author

Emma J. Beddowes

Guy's HospitalORCID 0000-0001-7649-2863Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Organism:human· 2 Approach:Bayesian inference· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Carlos CaldasiD· 2 shared Maurizio CallariiD· 2 shared Meiling GaoiD· 2 shared Stephen‐John SammutiD· 2 shared Suet‐Feung ChiniD· 2 shared Abdelhamid Boumertit· 1 shared Alistair G. MartiniD· 1 shared Anja BrouweriD· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Carlos CaldasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMar 3, 2023

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

Emma J. Beddowes, Mario Ortega Duran, Solon Karapanagiotis…·Carlos Caldas

This study uses ctDNA from metastatic breast cancer patients and a Bayesian model to predict treatment response and progression-free survival, outperforming alternative methods.

1 citation

humanDNA methylation

𝕏 PostBluesky

GenomicsGenome MedicinePeer-reviewedJan 4, 2019

Next Generation-Targeted Amplicon Sequencing (NG-TAS): An optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

Meiling Gao, Maurizio Callari, Emma J. Beddowes…·Carlos Caldas

NG-TAS is a cost-effective method for profiling ctDNA mutations in cancer patients, showing consistent detection of mutations at >1% allele fraction.

66 citations

humanDNA methylation

𝕏 PostBluesky